168 related articles for article (PubMed ID: 38355847)
1. Taurine, a Naturally Occurring Amino Acid, as a Physical Stability Enhancer of Different Monoclonal Antibodies.
Sreenivasan S; Rathore AS
AAPS J; 2024 Feb; 26(1):25. PubMed ID: 38355847
[TBL] [Abstract][Full Text] [Related]
2. Polysorbates versus Hydroxypropyl Beta-Cyclodextrin (HPβCD): Comparative Study on Excipient Stability and Stabilization Benefits on Monoclonal Antibodies.
Zhang H; Hong S; Tan SSK; Peng T; Goh LYH; Lam KH; Chow KT; Gokhale R
Molecules; 2022 Oct; 27(19):. PubMed ID: 36235038
[TBL] [Abstract][Full Text] [Related]
3. Edetate Disodium as a Polysorbate Degradation and Monoclonal Antibody Oxidation Stabilizer.
Yarbrough M; Hodge T; Menard D; Jerome R; Ryczek J; Moore D; Baldus P; Warne N; Ohtake S
J Pharm Sci; 2019 Apr; 108(4):1631-1635. PubMed ID: 30502482
[TBL] [Abstract][Full Text] [Related]
4. Characterization and stability study of polysorbate 20 in therapeutic monoclonal antibody formulation by multidimensional ultrahigh-performance liquid chromatography-charged aerosol detection-mass spectrometry.
Li Y; Hewitt D; Lentz YK; Ji JA; Zhang TY; Zhang K
Anal Chem; 2014 May; 86(10):5150-7. PubMed ID: 24749737
[TBL] [Abstract][Full Text] [Related]
5. A Comprehensive Assessment of All-Oleate Polysorbate 80: Free Fatty Acid Particle Formation, Interfacial Protection and Oxidative Degradation.
Doshi N; Giddings J; Luis L; Wu A; Ritchie K; Liu W; Chan W; Taing R; Chu J; Sreedhara A; Kannan A; Kei P; Shieh I; Graf T; Hu M
Pharm Res; 2021 Mar; 38(3):531-548. PubMed ID: 33713012
[TBL] [Abstract][Full Text] [Related]
6. High throughput multidimensional liquid chromatography approach for online protein removal and characterization of polysorbates and poloxamer in monoclonal antibody formulations.
Zegota MM; Schuster G; De Pra M; Müllner T; Menzen T; Steiner F; Hawe A
J Chromatogr A; 2024 Apr; 1720():464777. PubMed ID: 38432108
[TBL] [Abstract][Full Text] [Related]
7. Combined Presence of Ferrous Ions and Hydrogen Peroxide in Normal Saline and In Vitro Models Induces Enhanced Aggregation of Therapeutic IgG due to Hydroxyl Radicals.
Sreenivasan S; Rathore AS
Mol Pharm; 2023 Jun; 20(6):3033-3048. PubMed ID: 37189260
[TBL] [Abstract][Full Text] [Related]
8. Characterization of outcomes of amino acid modifications using a combinatorial approach to reveal physical and structural perturbations: A case study using trastuzumab biosimilar.
Kamble R; Puranik A; Narvekar A; Dandekar P; Jain R
J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Oct; 1209():123430. PubMed ID: 35988497
[TBL] [Abstract][Full Text] [Related]
9. Differential Surface Adsorption Phenomena for Conventional and Novel Surfactants Correlates with Changes in Interfacial mAb Stabilization.
Kanthe AD; Carnovale MR; Katz JS; Jordan S; Krause ME; Zheng S; Ilott A; Ying W; Bu W; Bera MK; Lin B; Maldarelli C; Tu RS
Mol Pharm; 2022 Sep; 19(9):3100-3113. PubMed ID: 35882380
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Polysorbate 80 Hydrolysis and Oxidation on the Aggregation of a Monoclonal Antibody.
Larson NR; Wei Y; Prajapati I; Chakraborty A; Peters B; Kalonia C; Hudak S; Choudhary S; Esfandiary R; Dhar P; Schöneich C; Middaugh CR
J Pharm Sci; 2020 Jan; 109(1):633-639. PubMed ID: 31758949
[TBL] [Abstract][Full Text] [Related]
11. Discovery and reduction of tryptophan oxidation-induced IgG1 fragmentation in a polysorbate 80-dependent manner.
Liu Y; Li H; Yan Z; Zhang L; Sun P
Eur J Pharm Biopharm; 2022 Apr; 173():45-53. PubMed ID: 35219863
[TBL] [Abstract][Full Text] [Related]
12. Effect of polysorbate 80 concentration on thermal and photostability of a monoclonal antibody.
Agarkhed M; O'Dell C; Hsieh MC; Zhang J; Goldstein J; Srivastava A
AAPS PharmSciTech; 2013 Mar; 14(1):1-9. PubMed ID: 23152309
[TBL] [Abstract][Full Text] [Related]
13. Effect of Polysorbate 20 and Polysorbate 80 on the Higher-Order Structure of a Monoclonal Antibody and Its Fab and Fc Fragments Probed Using 2D Nuclear Magnetic Resonance Spectroscopy.
Singh SM; Bandi S; Jones DNM; Mallela KMG
J Pharm Sci; 2017 Dec; 106(12):3486-3498. PubMed ID: 28843351
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Protein Particle Formation in IgG1 mAbs Formulated with PS20 Vs. PS80 When Subjected to Interfacial Dilatational Stress.
Vaclaw C; Merritt K; Griffin VP; Whitaker N; Gokhale M; Volkin DB; Ogunyankin MO; Dhar P
AAPS PharmSciTech; 2023 Apr; 24(5):104. PubMed ID: 37081185
[TBL] [Abstract][Full Text] [Related]
15. Mechanistic understanding of metal-catalyzed oxidation of polysorbate 80 and monoclonal antibody in biotherapeutic formulations.
Bensaid F; Dagallier C; Authelin JR; Audat H; Filipe V; Narradon C; Guibal P; Clavier S; Wils P
Int J Pharm; 2022 Mar; 615():121496. PubMed ID: 35074436
[TBL] [Abstract][Full Text] [Related]
16. Formulating monoclonal antibodies as powders for reconstitution at high concentration using spray-drying: Trehalose/amino acid combinations as reconstitution time reducing and stability improving formulations.
Massant J; Fleurime S; Batens M; Vanhaerents H; Van den Mooter G
Eur J Pharm Biopharm; 2020 Nov; 156():131-142. PubMed ID: 32882422
[TBL] [Abstract][Full Text] [Related]
17. A Mechanistic Understanding of Monoclonal Antibody Interfacial Protection by Hydrolytically Degraded Polysorbate 20 and 80 under IV Bag Conditions.
Kannan A; Giddings J; Mehta S; Lin T; Tomlinson A; Ritchie K; Shieh I; Saggu M; Doshi N
Pharm Res; 2022 Mar; 39(3):563-575. PubMed ID: 35277841
[TBL] [Abstract][Full Text] [Related]
18. Fatty Acids Can Induce the Formation of Proteinaceous Particles in Monoclonal Antibody Formulations.
Zhang J; He J; Smith KJ
J Pharm Sci; 2022 Mar; 111(3):655-662. PubMed ID: 34666046
[TBL] [Abstract][Full Text] [Related]
19. Kinetic Modeling of Methionine Oxidation in Monoclonal Antibodies from Hydrogen Peroxide Spiking Studies.
Hui A; Lam XM; Kuehl C; Grauschopf U; Wang YJ
PDA J Pharm Sci Technol; 2015; 69(4):511-25. PubMed ID: 26242787
[TBL] [Abstract][Full Text] [Related]
20. Characterization of Polysorbate Ester Fractions and Implications in Protein Drug Product Stability.
Tomlinson A; Zarraga IE; Demeule B
Mol Pharm; 2020 Jul; 17(7):2345-2353. PubMed ID: 32442382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
